畜牧兽医学报 ›› 2011, Vol. 42 ›› Issue (3): 402-408.doi:

• 预防兽医 • 上一篇    下一篇

鸡β-防御素-1对鸡传染性法氏囊病病毒VP2基因DNA疫苗的免疫佐剂作用

张辉华1*,杨小梅2,谢青梅2,马静云2,罗艳娜1,2,曹永长3,毕英佐2,3   

  1. 1.佛山科技学院生命科学院,佛山 528231;2.华南农业大学动物科学学院,广州 510642; 3.中山大学生命科学学院,广州 510275
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2011-03-25 发布日期:2011-03-25
  • 通讯作者: 张辉华

The Adjuvant Effects of Chicken β-defensin-1 on Infectious Bursal Disease Virus VP2 Gene DNA Vaccine

ZHANG Hui-hua1*, YANG Xiao-mei2, XIE Qing-mei2, MA Jing-yun2, LUO Yan-na1,2, CAO Yong-chang3, BI Ying-zuo2,3   

  1. 1. College of Life Sciences, Foshan University, Foshan 528231, Guangdong, China;2. College of Animal Science, South China Agricultural University, Guangzhou 510642, China;3. College of Life Sciences, Sun Yatsen University, Guangzhou 510275, China
  • Received:1900-01-01 Revised:1900-01-01 Online:2011-03-25 Published:2011-03-25

摘要: 本文旨在研究鸡β-防御素-1(AvBD1)对鸡IBDV VP2基因DNA疫苗的免疫佐剂作用。通过基因工程技术,构建真核表达质粒pcDNA3.1(+)-AvBD1与pcDNA3.1(+)-VP2。14日龄岭南黄肉鸡随机分成5组,分别免疫PBS、空质粒载体pcDNA3.1(+)、重组质粒pcDNA3.1(+)-VP2、重组质粒pcDNA3.1(+)-AvBD1与pcDNA3.1(+)-VP2联合免疫、IBD弱毒苗。收集免疫后不同时期的外周血血清样本,用ELISA方法检测血清中IBDV VP2特异性抗体水平,通过流式细胞仪检测CD3+、CD4+与CD8+T淋巴细胞的含量。结果表明,联合免疫组(即pcDNA3.1(+)AvBD1与pcDNA3.1(+)-VP2共同免疫)VP2特异性抗体水平显著高于其他组;单独免疫质粒pcDNA3.1(+)-VP2组VP2特异性抗体水平与免疫IBD弱毒苗组相当,显著高于PBS组与空质粒载体pcDNA3.1(+)组。在二免后第7天,联合免疫组外周血中CD3+、CD4+与CD8+T淋巴细胞的含量也显著高于单独免疫质粒pcDNA3.1(+)-VP2组,其它时间无显著性差异。IBDV攻毒后的保护率也是联合免疫组高于单独免疫pcDNA3.1(+)-VP2组。这些结果表明,鸡AvBD1可以作为一种免疫佐剂用于增强IBDV VP2基因DNA疫苗的免疫力。

Abstract: The aim of present study was to investigate the adjuvant effects of chicken β-defensin-1 (also named avian β-defensin-1, AvBD1) on DNA vaccine encoding chicken infectious bursal disease virus (IBDV) VP2 gene. The eukaryotic expression vectors pcDNA3.1(+)-AvBD1 and pcDNA3.1(+)-VP2 were constructed. Five groups of 14-day-old chickens were intramuscularly injected with PBS, empty vector pcDNA3.1(+), pcDNA3.1(+)-VP2, a mixtures of pcDNA3.1(+)-AvBD1 and pcDNA3.1(+)-VP2, and IBD attenuated vaccine, respectively. Serum of chicken in each group was collected from the peripheral blood at different time post inoculation, and VP2specific antibody was measured by ELISA. Content of CD3+, CD4+ and CD8+ T-lymphocytes in each group of chickens were tested by cytospectrometry. Results showed that VP2-specific antibody level of group immunized with a mixtures of pcDNA3.1(+)-AvBD1 and pcDNA3.1(+)-VP2 was the highest among all the groups. The VP2-specific antibody level of group immunized with pcDNA3.1(+)-VP2, as well as group immunized with IBD attenuated vaccine, was significantly higher than that of the group immunized with PBS and empty vector pcDNA3.1(+). The percentages of CD3+, CD4+ and CD8+ T-cell subtypes between groups of pcDNA3.1(+)-VP2 and pcDNA3.1(+)-VP2 combination with pcDNA3.1(+)-AvBD1 was significantly different (P<0.05), the latter was higher, at 7 days post boost. The protection from IBD challenged by immunized chickens with DNA vaccines encoding IBDV VP2 gene alone was lower than that by immunized with a mixtures of pcDNA3.1(+)-AvBD1 and pcDNA3.1(+)-VP2. The results indicated that AvBD1 can be used as an adjuvant to enhance the IBDV VP2 DNA vaccine immunity.